NYSE:AMPE

Ampio Pharmaceuticals Stock Signals

etoro logo Buy AMPE
*Your capital is at risk
$0.183
+0 (+0%)
At Close: Jul 31, 2026

Latest Data & Signals Issued

Below are some of the latest signals issued for Ampio Pharmaceuticals Inc

General

Signal Type Signal Value Data
Score 0.000 99 days ( 34.61 %
Last Price $0.183 0 %
Performance History
7 Days
$0.183 $0.183
0%
30 Days
$0.183 $0.183
0%
12 Mos
$0.0836 $0.183
119.02%

6/18

Active Buy Signals

Specific Signals

Short Term
Net score: 54.73
Signal Type Signal Value Importance Data
High / Low N/A Very Low $0.183 - $0.183
Trend - 3 mos 39.85 % High Width: 239.80 %
Pred. range - 3 mos $0.0916 - $0.311 Low -49.99 % - 69.94 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Sell Very Low Jul 30, 2026 - 2 days
RSI Short Pivot Signal Sell Very Low Nov 30, -0001 - N/A days
Short MA 3 mos Sell Low Nov 30, -0001 - N/A days
Long MA 3 mos Buy Medium May 20, 2026 - 50 days
Short/Long MA 3 mos Buy Medium May 20, 2026 - 50 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 45.67
Signal Type Signal Value Importance Data
Trend - 12 mos 112.53 % Very High Width: 556.89 %
Pred. range - 12 mos $0.115 - $0.759 High -36.93 % - 314.27 %
Short MA 12 mos Buy Very High May 07, 2026 - 59 days
Long MA 12 mos Sell Very High Jul 17, 2026 - 11 days
Short/Long MA 12 mos Sell Very High Jul 17, 2026 - 11 days
Pivot Long Sell Low Jul 30, 2026 - 2 days
RSI Long Pivot Signal Buy Low May 27, 2026 - 46 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT AMPIO PHARMACEUTICALS INC
Ampio Pharmaceuticals
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an intravenous ampion treatment that is in Phase II clinical trial to treat adult COVID-19 patients requi...
GOLDEN STAR
Ticker Change Signal Date
FOX
$50.81
2.22% Jul 27
UNFI
$49.05
3.63% Jul 27
BIIB
$202.19
0.376% Jul 24
TSCO
$30.32
1.48% Jul 23
S
SW
$43.71
5.17% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE